Skip to content
Screener

Schrodinger SDGR Total Operating Expenses

Total Operating Expenses at other companies

Simulations Plus logo
Simulations PlusSLP
$10.63M-87.8%
Absci Corporation logo
Absci CorporationABSI
$34.48M+7.8%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$66.83M+0.2%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$91.17M+17.6%
Certara, Inc. logo
Certara, Inc.CERT
$69.6M+22.4%
Sutro Biopharma logo
Sutro BiopharmaSTRO
$39.73M-40.8%

Other financials

Income statement

See full
Revenue$58.9M+7.5%
Gross profit$32.4M+24.0%
Operating income-$41.5M+21.5%
Net income$6.0M+114%
EPS (diluted)$0.08+114%

Balance sheet

See full
Cash & equivalents$292.9M+26.3%
Total debt$108.0M-5.5%
Total equity$329.0M-4.1%
Total assets$640.4M-7.0%

Cash flow

See full
Operating cash flow-$34.1M
CapEx$362.0K+15.3%
Free cash flow-$34.4M

Valuation

See full
Market cap$1.4B+2.4%
Enterprise value$1.22B-2.7%
P/S5.4×-0.3×

Profitability

See full
Gross margin56.9%-1.6pp
Operating margin-59.2%-12.6pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.6×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Schrodinger’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001490978-26-000068
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development40,99843,13884,82288,982
Sales and marketing10,26610,73421,86921,101
General and administrative (includes related party expense of $165, $109, $330 and $218)22,71525,18945,62950,991
Total operating expenses73,97979,061152,320161,074
Loss from operations(41,547)(52,903)(90,341)(103,792)
Other income (expense):
Change in fair value of equity investments45,8684,57932,381(8,516)
Other income3,0265,4385,6899,642

Item 1. Financial Statements.

FAQ

What is Schrodinger's total operating expenses?
Schrodinger (SDGR) reported total operating expenses of $73.98M in Q2 2026.
How has Schrodinger's total operating expenses changed year-over-year?
Schrodinger's total operating expenses decreased by 6.4% year-over-year, from $79.06M to $73.98M.
What is the long-term trend for Schrodinger's total operating expenses?
Over 4 years (2021 to 2025), Schrodinger's total operating expenses has grown at a 15.0% compound annual growth rate (CAGR), from $177.06M to $309.51M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Schrodinger's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude